Canaccord lowered the firm’s price target on Cresco Labs (CRLBF) to C$2.25 from C$2.50 and keeps a Speculative Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRLBF:
- Cresco Labs Grows Cash Flow and Margins Despite 2025 Impairment Charges
- Is CRLBF a Buy, Before Earnings?
- Cresco Labs Sets March 5 Date to Report Q4 and Full-Year 2025 Results
- Cresco Labs Launches US$100 Million At-the-Market Equity Program
- Cresco Labs Expands Florida Footprint With New Sunnyside Tamarac Dispensary